TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET 28
1.4 CURRENCY AND PRICING 29
1.5 LIMITATIONS 29
1.6 MARKETS COVERED 30
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 RESEARCH METHODOLOGY 36
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.7 DBMR MARKET POSITION GRID 40
2.8 DBMR VENDOR SHARE ANALYSIS 41
2.9 MULTIVARIATE MODELING 42
2.10 PRODUCTS LIFELINE CURVE 42
2.11 SECONDARY SOURCES 43
2.12 ASSUMPTIONS 43
3 MARKET OVERVIEW 44
3.1 DRIVERS 46
3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY 46
3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS 46
3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE 47
3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS 47
3.2 RESTRAINT 48
3.2.1 STRINGENT GOVERNMENTAL REGULATIONS 48
3.3 OPPORTUNITIES 49
3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS 49
3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS 49
3.4 CHALLENGE 50
3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING 50
4 EXECUTIVE SUMMARY 51
5 PREMIUM INSIGHTS 54
6 INDUSTRY INSIGHTS 55
7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE 56
7.1 OVERVIEW 57
7.2 ASEPTIC ISOLATORS 58
7.3 CONTAINMENT ISOLATORS 59
7.4 BIO ISOLATORS 60
7.5 SAMPLING AND WEIGHING ISOLATORS 61
7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS 62
7.7 OTHERS 63
8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE 64
8.1 OVERVIEW 65
8.2 CLASS III 67
8.3 ISO CLASS 5 68
9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE 69
9.1 OVERVIEW 70
9.2 CLOSED SYSTEM 71
9.3 OPEN SYSTEM 72
10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE 73
10.1 OVERVIEW 74
10.2 POSITIVE PRESSURE 75
10.3 NEGATIVE PRESSURE 76
11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION 77
11.1 OVERVIEW 78
11.2 FLOOR STANDING 79
11.3 MOBILE 80
11.4 COMPACT 81
11.5 MODULAR 82
11.6 TABLE TOP 83
11.7 PORTABLE 84
?
12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION 85
12.1 OVERVIEW 86
12.2 STERILITY TESTING 87
12.3 PHARMACEUTICAL INDUSTRY 88
12.4 MICROBIOLOGY SAFETY CABINETS 89
12.5 SAMPLING/ WEIGHING/ DISTRIBUTION 90
12.6 ANIMAL LABORATORIES 91
12.7 MEDICAL DEVICE MANUFACTURING 92
12.8 OTHERS 93
13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER 94
13.1 OVERVIEW 95
13.2 HOSPITALS 96
13.3 DIAGNOSTIC LABORATORIES 96
13.4 ACADEMIC AND RESEARCH INSTITUTES 97
13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 97
13.6 CONTRACT RESEARCH ORGANIZATION 98
14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL 99
14.1 OVERVIEW 100
14.2 DIRECT TENDER 101
14.3 RETAILER 102
15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY 103
15.1 OVERVIEW 104
15.2 NORTH AMERICA 109
15.2.1 U.S. 115
15.2.2 CANADA 118
15.2.3 MEXICO 121
15.3 EUROPE 124
15.3.1 GERMANY 130
15.3.2 FRANCE 133
15.3.3 ITALY 136
15.3.4 U.K. 139
15.3.5 SPAIN 142
15.3.6 SWITZERLAND 145
15.3.7 RUSSIA 148
15.3.8 NETHERLANDS 151
15.3.9 BELGIUM 154
15.3.10 TURKEY 157
15.3.11 REST OF EUROPE 159
15.4 ASIA-PACIFIC 160
15.4.1 JAPAN 166
15.4.2 CHINA 169
15.4.3 INDIA 172
15.4.4 SOUTH KOREA 175
15.4.5 AUSTRALIA 178
15.4.6 SINGAPORE 181
15.4.7 MALAYSIA 184
15.4.8 THAILAND 187
15.4.9 INDONESIA 190
15.4.10 PHILIPPINES 193
15.4.11 REST OF ASIA-PACIFIC 196
15.5 SOUTH AMERICA 197
15.5.1 BRAZIL 203
15.5.2 REST OF SOUTH AMERICA 205
15.6 MIDDLE EAST AFRICA 206
15.6.1 SOUTH AFRICA 212
15.6.2 REST OF MIDDLE EAST & AFRICA 215
16 GLOBAL PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE 216
16.1 COMPANY SHARE ANALYSIS: GLOBAL 216
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 217
16.3 COMPANY SHARE ANALYSIS: EUROPE 218
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 219
17 COMPANY PROFILE 220
17.1 SKAN AG 220
17.1.1 COMPANY SNAPSHOT 220
17.1.2 SWOT ANALYSIS 220
17.1.3 COMPANY SHARE ANALYSIS 221
17.1.4 GEOGRAPHICAL PRESENCE 222
17.1.5 PRODUCT PORTFOLIO 222
17.1.6 RECENT DEVELOPMENTS 223
17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 223
17.2 COMECER S.P.A. 224
17.2.1 COMPANY SNAPSHOT 224
17.2.2 SWOT ANALYSIS 224
17.2.3 COMPANY SHARE ANALYSIS 225
17.2.4 GEOGRAPHICAL PRESENCE 225
17.2.5 PRODUCT PORTFOLIO 226
17.2.6 RECENT DEVELOPMENTS 227
17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 228
17.3 GETINGE AB. 229
17.3.1 COMPANY SNAPSHOT 229
17.3.2 SWOT ANALYSIS 229
17.3.3 REVENUE ANALYSIS 230
17.3.4 COMPANY SHARE ANALYSIS 231
17.3.5 GEOGRAPHICAL PRESENCE 231
17.3.6 PRODUCT PORTFOLIO 232
17.3.7 RECENT DEVELOPMENTS 233
17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 233
17.4 WABASH NATIONAL CORPORATION 234
17.4.1 COMPANY SNAPSHOT 234
17.4.2 SWOT ANALYSIS 234
17.4.3 REVENUE ANALYSIS 235
17.4.4 COMPANY SHARE ANALYSIS 235
17.4.5 GEOGRAPHICAL PRESENCE 236
17.4.6 PRODUCT PORTFOLIO 236
17.4.7 RECENT DEVELOPMENTS 237
17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS 237
17.5 A. ROVANA LTD. 238
17.5.1 COMPANY SNAPSHOT 238
17.5.2 PRODUCT PORTFOLIO 238
17.5.3 RECENT DEVELOPMENTS 239
17.6 AZBIL CORPORATION 240
17.6.1 COMPANY SNAPSHOT 240
17.6.2 REVENUE ANALYSIS 240
17.6.3 GEOGRAPHICAL PRESENCE 241
17.6.4 PRODUCT PORTFOLIO 241
17.6.5 RECENT DEVELOPMENTS 241
17.7 BIOQUELL INC 242
17.7.1 COMPANY SNAPSHOT 242
17.7.2 GEOGRAPHICAL PRESENCE 242
17.7.3 PRODUCT PORTFOLIO 243
17.7.4 RECENT DEVELOPMENTS 243
17.8 CHIYODA CORPORATION 244
17.8.1 COMPANY SNAPSHOT 244
17.8.2 REVENUE ANALYSIS 244
17.8.3 GEOGRAPHICAL PRESENCE 245
17.8.4 PRODUCT PORTFOLIO 245
17.8.5 RECENT DEVELOPMENTS 245
17.9 ENVAIR LIMITED 246
17.9.1 COMPANY SNAPSHOT 246
17.9.2 GEOGRAPHICAL PRESENCE 246
17.9.3 PRODUCT PORTFOLIO 247
17.9.4 RECENT DEVELOPMENTS 247
17.10 ESCO GROUP OF COMPANIES 248
17.10.1 COMPANY SNAPSHOT 248
17.10.2 GEOGRAPHICAL PRESENCE 248
17.10.3 PRODUCT PORTFOLIO 249
17.10.4 RECENT DEVELOPMENT 250
17.11 FEDEGARI AUTOCLAVI S.P.A 251
17.11.1 COMPANY SNAPSHOT 251
17.11.2 GEOGRAPHICAL PRESENCE 251
17.11.3 PRODUCT PORTFOLIO 252
17.11.4 RECENT DEVELOPMENT 252
17.12 GERMFREE 253
17.12.1 COMPANY SNAPSHOT 253
17.12.2 PRODUCT PORTFOLIO 253
17.12.3 RECENT DEVELOPMENTS 253
17.13 HECHT TECHNOLOGIE GMBH 254
17.13.1 COMPANY SNAPSHOT 254
17.13.2 PRODUCT PORTFOLIO 254
17.13.3 RECENT DEVELOPMENTS 254
17.14 HOSOKAWA 255
17.14.1 COMPANY SNAPSHOT 255
17.14.2 REVENUE ANALYSIS 255
17.14.3 GEOGRAPHICAL PRESENCE 256
17.14.4 PRODUCT PORTFOLIO 256
17.14.5 RECENT DEVELOPMENTS 256
17.15 ITECO S.R.L. 257
17.15.1 COMPANY SNAPSHOT 257
17.15.2 GEOGRAPHICAL PRESENCE 257
17.15.3 PRODUCT PORTFOLIO 258
17.15.4 RECENT DEVELOPMENTS 259
17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. 260
17.16.1 COMPANY SNAPSHOT 260
17.16.2 REVENUE ANALYSIS 260
17.16.3 GEOGRAPHICAL PRESENCE 261
17.16.4 PRODUCT PORTFOLIO 261
17.16.5 RECENT DEVELOPMENT 261
17.17 JACOMEX 262
17.17.1 COMPANY SNAPSHOT 262
17.17.2 GEOGRAPHICAL PRESENCE 262
17.17.3 PRODUCT PORTFOLIO 263
17.17.4 RECENT DEVELOPMENTS 263
17.18 MBRAUN 264
17.18.1 COMPANY SNAPSHOT 264
17.18.2 GEOGRAPHICAL PRESENCE 264
17.18.3 PRODUCT PORTFOLIO 265
17.18.4 RECENT DEVELOPMENTS 266
17.19 NUAIRE 267
17.19.1 COMPANY SNAPSHOT 267
17.19.2 PRODUCT PORTFOLIO 267
17.19.3 RECENT DEVELOPMENT 267
17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH 268
17.20.1 COMPANY SNAPSHOT 268
17.20.2 GEOGRAPHICAL PRESENCE 268
17.20.3 PRODUCT PORTFOLIO 269
17.20.4 RECENT DEVELOPMENTS 269
17.21 ROBERT BOSCH GMBH 270
17.21.1 COMPANYSNAPSHOT 270
17.21.2 REVENUE ANALYSIS 270
17.21.3 GEOGRAPHICAL PRESENCE 271
17.21.4 PRODUCT PORTFOLIO 271
17.21.5 RECENT DEVELOPMENTS 271
17.22 STERILINE S.R.L. 272
17.22.1 COMPANY SNAPSHOT 272
17.22.2 PRODUCT PORTFOLIO 272
17.22.3 RECENT DEVELOPMENTS 272
17.23 TAILIN 273
17.23.1 COMPANY SNAPSHOT 273
17.23.2 PRODUCT PORTFOLIO 273
17.23.3 RECENT DEVELOPMENTS 274
17.24 TEMA SINERGIE S.P.A 275
17.24.1 COMPANY SNAPSHOT 275
17.24.2 PRODUCT PORTFOLIO 275
17.24.3 RECENT DEVELOPMENTS 276
?
17.25 VANRX PHARMASYSTEMS INC. 277
17.25.1 COMPANY SNAPSHOT 277
17.25.2 PRODUCT PORTFOLIO 277
17.25.3 RECENT DEVELOPMENTS 278
18 CONCLUSION 279
19 QUESTIONNAIRE 280
20 RELATED REPORTS 283